$0981.HK: The US just closed the last big loophole in AI export controls — and Bernstein says China's chipmakers win. Outperform, HK$100 target vs HK$49.20 cited (17 Nov).
BIS's 16 Nov rule extends controls from shipping chips to remote access to AI compute: overseas data centres offering over 12M TPP (~750 H100/H200) to China-linked users now need a licence.
Bernstein: a headwind for China's hyperscalers and AI labs — frontier compute gets pricier and scarcer. Domestic chip makers gain pricing power: Cambricon and Hygon first, via 2027 ASPs and margins, not volumes, as HBM supply binds. SMIC's advanced logic turns strategic; NAURA, AMEC, Piotech are "the ultimate beneficiary".
Valuation: SMIC-H at 39.3x 2026E EPS ($0.16) and 29.1x 2027E ($0.22); the HK$100 target implies ~103% upside.
Unhidea take: the shift is from chips to compute — scarcity is now structural, and that makes domestic capacity valuable.
Unhidea take: watch the MATCH Act — a DUV ban would hit the same fabs; Bernstein's key risk, with a US–China "cease fire" the likely endgame.
Risks: MATCH Act, China rare-earth retaliation, more controls. Source: Bernstein, 18 Nov 2026. Not financial advice.
BIS's 16 Nov rule extends controls from shipping chips to remote access to AI compute: overseas data centres offering over 12M TPP (~750 H100/H200) to China-linked users now need a licence.
Bernstein: a headwind for China's hyperscalers and AI labs — frontier compute gets pricier and scarcer. Domestic chip makers gain pricing power: Cambricon and Hygon first, via 2027 ASPs and margins, not volumes, as HBM supply binds. SMIC's advanced logic turns strategic; NAURA, AMEC, Piotech are "the ultimate beneficiary".
Valuation: SMIC-H at 39.3x 2026E EPS ($0.16) and 29.1x 2027E ($0.22); the HK$100 target implies ~103% upside.
Unhidea take: the shift is from chips to compute — scarcity is now structural, and that makes domestic capacity valuable.
Unhidea take: watch the MATCH Act — a DUV ban would hit the same fabs; Bernstein's key risk, with a US–China "cease fire" the likely endgame.
Risks: MATCH Act, China rare-earth retaliation, more controls. Source: Bernstein, 18 Nov 2026. Not financial advice.
